- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Stable Growth Stocks
Swiss Pharmaceuticals & Biotech Stable Growth Stocks
Results
2
0 new
2 companies
Novartis
Market Cap: CHF 181.7b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 92.73
7D
-1.1%
1Y
2.5%
Siegfried Holding
Market Cap: CHF 4.3b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 98.10
7D
2.3%
1Y
12.0%